Phase 2b Randomized, Double-Blind, Placebo- and Active-Controlled Bunionectomy Trial
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
This is a Phase 2b, randomized, double blind, placebo and active controlled study with an
Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing
bunionectomy.